duocarmycin sa has been researched along with dactinomycin in 1 studies
| Studies (duocarmycin sa) | Trials (duocarmycin sa) | Recent Studies (post-2010) (duocarmycin sa) | Studies (dactinomycin) | Trials (dactinomycin) | Recent Studies (post-2010) (dactinomycin) |
|---|---|---|---|---|---|
| 75 | 0 | 15 | 19,045 | 355 | 969 |
| Protein | Taxonomy | duocarmycin sa (IC50) | dactinomycin (IC50) |
|---|---|---|---|
| RAD51 | Homo sapiens (human) | 32.1 | |
| Growth factor receptor-bound protein 2 | Homo sapiens (human) | 5 | |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | 9 | |
| Growth factor receptor-bound protein 2 | Mus musculus (house mouse) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikariyama, Y; Kuwabara, T; Noda, T; Ohtake, H; Ohtake, T; Toyama, S | 1 |
1 other study(ies) available for duocarmycin sa and dactinomycin
| Article | Year |
|---|---|
Classification of DNA-binding mode of antitumor and antiviral agents by the electrochemiluminescence of ruthenium complex.
Topics: Antineoplastic Agents; Antiviral Agents; Cisplatin; Dactinomycin; Distamycins; DNA; Dose-Response Relationship, Drug; Duocarmycins; Electrochemistry; Indoles; Luminescent Measurements; Macromolecular Substances; Mitomycin; Molecular Structure; Pyrroles; Ruthenium | 2003 |